Ligand: Q2 Earnings Snapshot
By AP News
Published - Aug 06, 2024, 04:28 PM ET
Last Updated - Aug 06, 2024, 04:28 PM EDT
JUPITER, Fla. (AP) — JUPITER, Fla. (AP) — Ligand Pharmaceuticals Inc. (LGND) on Tuesday reported a loss of $51.9 million in its second quarter.
On a per-share basis, the Jupiter, Florida-based company said it had a loss of $2.88. Earnings, adjusted for one-time gains and costs, came to $1.40 per share.
The drugmaker posted revenue of $41.5 million in the period.
Ligand expects full-year earnings in the range of $5 to $5.50 per share, with revenue in the range of $140 million to $157 million.
